SPRO - スマ―トプロス (Spero Therapeutics Inc.) スマ―トプロス

 SPROのチャート


 SPROの企業情報

symbol SPRO
会社名 SmartPros Ltd (スマ―トプロス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   工業(Industrials)
概要 事業概要 スペル・セラピューティックス(Spero Therapeutics Inc.)は臨床段階のバイオ医薬品会社である。同社は、MDR細菌感染の新規治療法の特定・開発・商業化に従事する。同社は、SPR994、増強剤プラットフォーム(SPR741とSPR206)、およびSPR720を含む新規製品候補のポートフォリオを開発している。SPR994はカルバペネム級の抗生物質であるテビペネムの新規経口製剤である。SPR994はMDR細菌感染に対して有効であり、その初期の焦点はcUTIの治療にある。ポテンシエータープラットフォームは、グラム陰性細菌に対する不活性抗生物質を含む既存の抗生物質のスペクトルおよび効力を拡大する薬物を開発することを可能にする。SPR720は、HIVを含む免疫系が損なわれた患者、または嚢胞性線維症、喘息及び気管支拡張症などの呼吸器疾患を有する患者にしばしば起こる、まれな肺感染であるNTMの治療のために設計された新規経口療法製品候補である。   スマ―トプロスは米国の教育サ―ビス会社。会計、金融サ―ビス、法務、エンジニアリング、証券、保険など、特定の市場を対象に教育・研修ソリュ―ションを提供。コ―スは、テキスト、ビデオ対話型、ライブ、オンラインセミナ―で利用できる。主な顧客は、大手企業及び、専門分野の会社や団体など。本社はニューヨーク州。   Spero Therapeutics, Inc. is a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug-resistant (MDR) bacterial infections and rare diseases.
本社所在地 12 Skyline Drive Hawthorne NY 10532 USA
代表者氏名 Milind S. Deshpande Milind S. Deshpande
代表者役職名 Independent Chairman of the Board
電話番号 +1 857-242-1600
設立年月日 29677
市場名 NASDAQ Small Cap
ipoyear 2017年
従業員数 57人
url www.smartpros.com
nasdaq_url https://www.nasdaq.com/symbol/spro
adr_tso
EBITDA EBITDA(百万ドル) -44.37100
終値(lastsale) 10.44
時価総額(marketcap) 189678398.76
時価総額 時価総額(百万ドル) 183.13780
売上高 売上高(百万ドル) 3.20600
企業価値(EV) 企業価値(EV)(百万ドル) 116.50080
当期純利益 当期純利益(百万ドル) -47.44600
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Spero Therapeutics Inc revenues increased from $389K to $1.6M. Net loss applicable to common stockholders increased 7% to $20.6M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Higher net loss reflects Research and development - Balancing val increase of 18% to $15.8M (expense).

 SPROのテクニカル分析


 SPROのニュース

   Spero Therapeutics antibiotic SPR206 shows promise in phase 1 trial  2022/02/16 14:06:09 Seeking Alpha
Spero Therapeutics (SPRO) reported positive results from a phase 1 trial of its antibiotic SPR206 to treat serious multi-drug resistant ((MDR)) gram-negative infections in the…
   Spero Therapeutics Sees Positive Topline Results for Antibiotic Trial  2022/02/16 13:17:00 MarketWatch
By Chris Wack Spero Therapeutics Inc. said it saw positive topline findings from its Phase 1 bronchoalveolar lavage clinical trial of SPR206, an…
   Spero granted up to $12.9M by BARDA to develop urinary tract infection drug for children  2022/01/19 20:22:45 Seeking Alpha
Spero Therapeutics <> said the Biomedical Advanced Research and Development Authority ((BARDA)) awarded up to an additional $12.9M to the company to to develop tebipenem as…
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/16 15:12:37 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 17.6% year-to-date, down 19.8% over the past 12 months, and up 587.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.9% above its 52-week low.Trading volume this week was 6.3% higher than the 10-day average and 2.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 334.8% The company's stock price performance over the past 12 months lags the peer average by -1539.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/15 02:50:09 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 25.5% year-to-date, down 25.8% over the past 12 months, and up 521.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.3% above its 52-week low.Trading volume this week was 12.9% higher than the 10-day average and 1.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.3% higher than its 5-day moving average, 4.3% lower than its 20-day moving average, and 18.1% lower than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 511.5% The company's stock price performance over the past 12 months lags the peer average by -1122.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero granted up to $12.9M by BARDA to develop urinary tract infection drug for children  2022/01/19 20:22:45 Seeking Alpha
Spero Therapeutics <> said the Biomedical Advanced Research and Development Authority ((BARDA)) awarded up to an additional $12.9M to the company to to develop tebipenem as…
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/16 15:12:37 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 17.6% year-to-date, down 19.8% over the past 12 months, and up 587.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.9% above its 52-week low.Trading volume this week was 6.3% higher than the 10-day average and 2.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 334.8% The company's stock price performance over the past 12 months lags the peer average by -1539.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/15 02:50:09 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 25.5% year-to-date, down 25.8% over the past 12 months, and up 521.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.3% above its 52-week low.Trading volume this week was 12.9% higher than the 10-day average and 1.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.3% higher than its 5-day moving average, 4.3% lower than its 20-day moving average, and 18.1% lower than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 511.5% The company's stock price performance over the past 12 months lags the peer average by -1122.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics (NASDAQ:SPRO) Shares Cross Below Two Hundred Day Moving Average of $15.95  2021/12/14 08:30:42 Dakota Financial News
Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.95 and traded as low as $13.27. Spero Therapeutics shares last traded at $13.65, with a volume of 107,572 shares trading hands. Several brokerages have recently issued reports on SPRO. […]
   California State Teachers Retirement System Grows Position in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/30 09:32:44 Dakota Financial News
California State Teachers Retirement System grew its stake in Spero Therapeutics, Inc. (NASDAQ:SPRO) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,446 shares of the companys stock after purchasing an additional 2,523 shares during the period. California State []
   Spero granted up to $12.9M by BARDA to develop urinary tract infection drug for children  2022/01/19 20:22:45 Seeking Alpha
Spero Therapeutics <> said the Biomedical Advanced Research and Development Authority ((BARDA)) awarded up to an additional $12.9M to the company to to develop tebipenem as…
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/16 15:12:37 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 17.6% year-to-date, down 19.8% over the past 12 months, and up 587.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.9% above its 52-week low.Trading volume this week was 6.3% higher than the 10-day average and 2.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 334.8% The company's stock price performance over the past 12 months lags the peer average by -1539.9% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics Inc Shares Close the Day 10.6% Higher - Daily Wrap  2022/01/15 02:50:09 Kwhen Finance
Spero Therapeutics Inc (SPRO) shares closed today 10.6% higher than it did at the end of yesterday. The stock is currently down 25.5% year-to-date, down 25.8% over the past 12 months, and up 521.4% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $13.45 and as low as $11.69 this week.Shares closed 40.6% below its 52-week high and 12.3% above its 52-week low.Trading volume this week was 12.9% higher than the 10-day average and 1.2% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.3. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 4.3% higher than its 5-day moving average, 4.3% lower than its 20-day moving average, and 18.1% lower than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 511.5% The company's stock price performance over the past 12 months lags the peer average by -1122.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Spero Therapeutics (NASDAQ:SPRO) Shares Cross Below Two Hundred Day Moving Average of $15.95  2021/12/14 08:30:42 Dakota Financial News
Shares of Spero Therapeutics, Inc. (NASDAQ:SPRO) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $15.95 and traded as low as $13.27. Spero Therapeutics shares last traded at $13.65, with a volume of 107,572 shares trading hands. Several brokerages have recently issued reports on SPRO. […]
   California State Teachers Retirement System Grows Position in Spero Therapeutics, Inc. (NASDAQ:SPRO)  2021/11/30 09:32:44 Dakota Financial News
California State Teachers Retirement System grew its stake in Spero Therapeutics, Inc. (NASDAQ:SPRO) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 33,446 shares of the companys stock after purchasing an additional 2,523 shares during the period. California State []

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 スマ―トプロス SPRO Spero Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)